Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Financing Activities ₹198 Cr₹80 Cr₹-15 Cr₹-114 Cr₹-21 Cr

What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?

The latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA is ₹198 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Financing Activities
Mar2023₹198 Cr
Mar2022₹80 Cr
Mar2021₹-15 Cr
Mar2020₹-114 Cr
Mar2019₹-21 Cr

How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2023 ₹198 Cr
148.81
Mar2022 ₹80 Cr
Positive
Mar2021 ₹-15 Cr
Negative
Mar2020 ₹-114 Cr
Negative
Mar2019 ₹-21 Cr -

Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,532.2 Cr -3.5% 5.3% 107.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-3.5%

5.3%

107.5%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses